<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08624001</doc-number>
<kind>B1</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>31</s160>
</s100>
<s200>
<s210>1</s210>
<s211>336</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      anti-CD19 antibody, cA19</s223>
</s220>
</s200>
<s400> 1
gac atc cag ctg acc cag tct cca gct tct ttg gct gtg tct cta ggg       48
Asp Ile Gln Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly
  1               5                  10                  15
cag agg gcc acc atc tcc tgc aag gcc agc caa agt gtt gat tat gat       96
Gln Arg Ala Thr Ile Ser Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
ggt gat agt tat ttg aac tgg tac caa cag att cca gga cag cca ccc      144
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Gln Pro Pro
         35                  40                  45
aaa ctc ctc atc tat gat gca tcc aat cta gtt tct ggc atc cca ccc      192
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
agg ttt agt ggc agt ggg tct ggg aca gac ttc acc ctc aac atc cat      240
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Asn Ile His
 65                  70                  75                  80
cct gtg gag aag gtg gat gct gca acc tat cac tgt cag caa agt act      288
Pro Val Glu Lys Val Asp Ala Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
gaa gat ccg tgg acg ttc ggt gga ggg acc aag ctg gag atc aaa cgt      336
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>2</s210>
<s211>112</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      anti-CD19 antibody, cA19</s223>
</s220>
</s200>
<s400> 2
Asp Ile Gln Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly
  1               5                  10                  15
Gln Arg Ala Thr Ile Ser Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Gln Pro Pro
         35                  40                  45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Asn Ile His
 65                  70                  75                  80
Pro Val Glu Lys Val Asp Ala Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>3</s210>
<s211>372</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      anti-CD19 antibody, cA19</s223>
</s220>
</s200>
<s400> 3
cag gtc caa ctg cag gag tct ggg gct gag ctg gtg agg cct ggg tcc       48
Gln Val Gln Leu Gln Glu Ser Gly Ala Glu Leu Val Arg Pro Gly Ser
  1               5                  10                  15
tca gtg aag att tcc tgc aag gct tct ggt tat gca ttc agt agc tac       96
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
tgg atg aac tgg gtg aag cag agg cct gga cag ggt ctt gag tgg att      144
Trp Met Asn Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
gga cag att tgg cct gga gat ggt gat act aac tac aat gga aag ttc      192
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
aag ggt aaa gcc act ctg act gcc gac gaa tcc tcc agc aca gcc tac      240
Lys Gly Lys Ala Thr Leu Thr Ala Asp Glu Ser Ser Ser Thr Ala Tyr
 65                  70                  75                  80
atg caa ctc agc agc cta cga tct gag gac tct gcg gtc tat tct tgt      288
Met Gln Leu Ser Ser Leu Arg Ser Glu Asp Ser Ala Val Tyr Ser Cys
                 85                  90                  95
gca aga cgg gag act acg acg gta ggc cgt tat tac tat gct atg gac      336
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
tac tgg ggc caa ggg acc acg gtc acc gtc tcc tca                      372
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>4</s210>
<s211>124</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      anti-CD19 antibody, cA19</s223>
</s220>
</s200>
<s400> 4
Gln Val Gln Leu Gln Glu Ser Gly Ala Glu Leu Val Arg Pro Gly Ser
  1               5                  10                  15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
Trp Met Asn Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
Lys Gly Lys Ala Thr Leu Thr Ala Asp Glu Ser Ser Ser Thr Ala Tyr
 65                  70                  75                  80
Met Gln Leu Ser Ser Leu Arg Ser Glu Asp Ser Ala Val Tyr Ser Cys
                 85                  90                  95
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>5</s210>
<s211>108</s211>
<s212>PRT</s212>
<s213>Homo sapiens</s213>
</s200>
<s400> 5
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
  1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ile Lys Tyr
             20                  25                  30
Leu Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Ile
         35                  40                  45
Tyr Glu Ala Asn Ser Leu Gln Ala Gly Val Pro Ser Arg Phe Ser Gly
     50                  55                  60
Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro
 65                  70                  75                  80
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Gln Ser Leu Pro Tyr
                 85                  90                  95
Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg
            100                 105
</s400>
<s200>
<s210>6</s210>
<s211>112</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Chimeric
      cA19Vk antibody</s223>
</s220>
</s200>
<s400> 6
Asp Ile Gln Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly
  1               5                  10                  15
Gln Arg Ala Thr Ile Ser Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Gln Pro Pro
         35                  40                  45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Asn Ile His
 65                  70                  75                  80
Pro Val Glu Lys Val Asp Ala Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Gln Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>7</s210>
<s211>112</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized hA19Vk antibody</s223>
</s220>
</s200>
<s400> 7
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
  1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Lys Ala Pro
         35                  40                  45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser
 65                  70                  75                  80
Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Gln Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>8</s210>
<s211>117</s211>
<s212>PRT</s212>
<s213>Homo sapiens</s213>
</s200>
<s400> 8
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
  1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
             20                  25                  30
Trp Leu His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
         35                  40                  45
Gly Gly Ile Val Pro Met Phe Gly Pro Pro Asn Tyr Ala Gln Lys Phe
     50                  55                  60
Gln Gly Arg Ala Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
 65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
                 85                  90                  95
Ala Gly Gly Tyr Gly Ile Tyr Ser Pro Glu Trp Gly Gln Gly Ser Leu
            100                 105                 110
Val Thr Val Ser Ser
        115
</s400>
<s200>
<s210>9</s210>
<s211>124</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Chimeric
      cA19VH antibody</s223>
</s220>
</s200>
<s400> 9
Gln Val Gln Leu Gln Glu Ser Gly Ala Glu Leu Val Arg Pro Gly Ser
  1               5                  10                  15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
Trp Met Asn Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
Lys Gly Lys Ala Thr Leu Thr Ala Asp Glu Ser Ser Ser Thr Ala Tyr
 65                  70                  75                  80
Met Gln Leu Ser Ser Leu Arg Ser Glu Asp Ser Ala Val Tyr Ser Cys
                 85                  90                  95
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>10</s210>
<s211>124</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized hA19VH antibody</s223>
</s220>
</s200>
<s400> 10
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
  1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
Trp Met Asn Trp Val Arg Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
Lys Gly Arg Ala Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
 65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Ser Cys
                 85                  90                  95
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>11</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Homo sapiens</s213>
</s200>
<s400> 11
Trp Gly Gln Gly Ser Leu Val Thr Val Ser Ser
  1               5                  10
</s400>
<s200>
<s210>12</s210>
<s211>336</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized anti-CD19 antibody, hA19Vk</s223>
</s220>
</s200>
<s400> 12
gac atc cag ctg acc cag tct cca tca tct ctg agc gca tct gtt gga       48
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
  1               5                  10                  15
gat agg gtc act atc act tgt aag gcc agc caa agt gtt gat tat gat       96
Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
ggt gat agt tat ttg aac tgg tac cag cag att cca ggg aaa gca cct      144
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Lys Ala Pro
         35                  40                  45
aaa ttg ttg atc tac gat gct tcg aat cta gtt tct ggt atc cct cct      192
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
cga ttc tct ggc agc gga tct ggg aca gat tac act ttc acc atc agc      240
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser
 65                  70                  75                  80
tct ctt caa cca gaa gac att gca aca tat cac tgt cag caa agt act      288
Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
gaa gat ccg tgg acg ttc ggt gga ggg acc aag cta cag atc aaa cgt      336
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Gln Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>13</s210>
<s211>112</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized anti-CD19 antibody, hA19Vk</s223>
</s220>
</s200>
<s400> 13
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
  1               5                  10                  15
Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp
             20                  25                  30
Gly Asp Ser Tyr Leu Asn Trp Tyr Gln Gln Ile Pro Gly Lys Ala Pro
         35                  40                  45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Val Ser Gly Ile Pro Pro
     50                  55                  60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser
 65                  70                  75                  80
Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr His Cys Gln Gln Ser Thr
                 85                  90                  95
Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Gln Ile Lys Arg
            100                 105                 110
</s400>
<s200>
<s210>14</s210>
<s211>372</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized anti-CD19 antibody, hA19VH</s223>
</s220>
</s200>
<s400> 14
cag gtc caa ctg cag caa tca ggg gct gaa gtc aag aaa cct ggg tca       48
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
  1               5                  10                  15
tcg gtg aag gtc tcc tgc aag gct tct ggc tac gct ttc agt agc tac       96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
tgg atg aac tgg gtg agg cag agg cct gga cag ggt ctt gag tgg att      144
Trp Met Asn Trp Val Arg Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
gga cag att tgg cct gga gat ggt gat act aac tac aat gga aag ttc      192
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
aag ggg cgc gcc act att act gcc gac gaa tcc act aat aca gcc tac      240
Lys Gly Arg Ala Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
 65                  70                  75                  80
atg gaa ctc agc agc cta cga tct gag gac aca gcg ttc tat tct tgt      288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Ser Cys
                 85                  90                  95
gca aga cgg gag act acg acg gta ggc cgt tat tac tat gct atg gac      336
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
tac tgg ggc caa ggg acc acg gtc acc gtc tcc tca                      372
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>15</s210>
<s211>124</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      humanized anti-CD19 antibody, hA19VH</s223>
</s220>
</s200>
<s400> 15
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
  1               5                  10                  15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ala Phe Ser Ser Tyr
             20                  25                  30
Trp Met Asn Trp Val Arg Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
         35                  40                  45
Gly Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe
     50                  55                  60
Lys Gly Arg Ala Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
 65                  70                  75                  80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Ser Cys
                 85                  90                  95
Ala Arg Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp
            100                 105                 110
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120
</s400>
<s200>
<s210>16</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 16
Lys Ala Ser Gln Ser Val Asp Tyr Asp Gly Asp Ser Tyr Leu Asn
  1               5                  10                  15
</s400>
<s200>
<s210>17</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 17
Asp Ala Ser Asn Leu Val Ser
  1               5
</s400>
<s200>
<s210>18</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 18
Gln Gln Ser Thr Glu Asp Pro Trp Thr
  1               5
</s400>
<s200>
<s210>19</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 19
Ser Tyr Trp Met Asn
  1               5
</s400>
<s200>
<s210>20</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 20
Gln Ile Trp Pro Gly Asp Gly Asp Thr Asn Tyr Asn Gly Lys Phe Lys
  1               5                  10                  15
Gly
</s400>
<s200>
<s210>21</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 21
Arg Glu Thr Thr Thr Val Gly Arg Tyr Tyr Tyr Ala Met Asp Tyr
  1               5                  10                  15
</s400>
<s200>
<s210>22</s210>
<s211>4</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide linker</s223>
</s220>
</s200>
<s400> 22
Gly Gly Gly Ser
  1
</s400>
<s200>
<s210>23</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide linker</s223>
</s220>
</s200>
<s400> 23
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
  1               5                  10                  15
</s400>
<s200>
<s210>24</s210>
<s211>126</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 24
atcacttgta aggccagcca aagtgttgat tatgatggtg atagttattt gaactggtac     60
cagcagattc cagggaaagc acctaaattg ttgatctacg atgcttcgaa tctagtttct    120
ggtatc                                                               126
</s400>
<s200>
<s210>25</s210>
<s211>125</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 25
tgctgacagt gatatgttgc aatgtcttct ggttgaagag agctgatggt gaaagtgtaa     60
tctgtcccag atccgctgcc agagaatcga ggagggatac cagaaactag attcgaagca    120
tcgta                                                                125
</s400>
<s200>
<s210>26</s210>
<s211>86</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 26
tccgacatcc agctgaccca gtctccatca tctctgagcg catctgttgg agatagggtc     60
actatcactt gtaaggccag ccaaag                                          86
</s400>
<s200>
<s210>27</s210>
<s211>81</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 27
gctccttgag atctgtagct tggtccctcc accgaacgtc cacggatctt cagtactttg     60
ctgacagtga tatgttgcaa t                                               81
</s400>
<s200>
<s210>28</s210>
<s211>137</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 28
ctggctacgc tttcagtagc tactggatga actgggtgag gcagaggcct ggacagggtc     60
ttgagtggat tggacagatt tggcctggag atggtgatac taactacaat ggaaagttca    120
aggggcgcgc cactatt                                                   137
</s400>
<s200>
<s210>29</s210>
<s211>129</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 29
cgtagtctcc cgtcttgcac aagaatagaa cgctgtgtcc tcagatcgta ggctgctgag     60
ttccatgtag gctgtattag tggattcgtc ggcagtaata gtggcgcgcc ccttgaactt    120
tccattgta                                                            129
</s400>
<s200>
<s210>30</s210>
<s211>93</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 30
caggtccaac tgcagcaatc aggggctgaa gtcaagaaac ctgggtcatc ggtgaaggtc     60
tcctgcaagg cttctggcta cgctttcagt agc                                  93
</s400>
<s200>
<s210>31</s210>
<s211>89</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      primer</s223>
</s220>
</s200>
<s400> 31
tgaggagacg gtgaccgtgg tcccttggcc ccagtagtcc atagcatagt aataacggcc     60
taccgtcgta gtctcccgtc ttgcacaag                                       89
</s400>
</sequence-list-new-rules>
</sequence-cwu>
